课题基金 / 基金详情

Contrast Agents for Far Red and Near Infrared Imaging

Contrast Agents for Far Red and Near Infrared Imaging
用于远红和近红外成像的造影剂
批准号:
6404648
负责人:
Brian David Gray
金额:
$49.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-03-17 至 2003-08-31

项目摘要

项目成果

Brian David Gray的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by Applicant): Tools to monitor immune cell interactions and their consequences will accelerate development of successful immunotherapies for cancer, HIV disease, and autoimmune disorders. High levels of autofluorescence and spectral overlap limit use of stable fluorescent labels for cell proteins or membranes with other visible probes. High levels of tissue absorption and scattering preclude real time optical imaging in intact animals. PTIR has synthesized five new cell tracking dyes fluorescing in the 667-837 nm range (far red - near infrared). S/N for labeled cells were up to 15x of those for PKH26; spectral overlap properties were suitable for use with many other fluorescent probes; and feasibility criteria for chemical stability, photostability, and lack of effect on cell viability and growth were met. Labeled cells were also readily imaged in superficial lung microvessels using intact organ microscopy and at subcutaneous injections sites in nude mice, attesting to the potential for noninvasive, whole body imaging. In Phase II PTIR will develop two kits f or preclinical use and screening and initiate studies to support a clinical cell tracking dye. The first kit will be for standard 3-4 color instruments, the second for high-end instrumentation. Our collaborators will evaluate both kits by monitoring proliferation of lymphocyte subsets, determining the depth to which tumor cells can be tracked in intact lung preparations from rats, and determining the minimum number of cells which can be imaged at deep vs. superficial sites in intact animals. PROPOSED COMMERCIAL APPLICATION: Membrane labeling dyes emitting in the far red or near infrared have significant commercial potential in three markets; 1) a research market serving both basic and clinical investigators using flow cytometers; 2) a similar and rapidly growing market in optical imaging, especially intact organ or whole body imaging; and for molecules with suitable photochemical properties, 3) photodiagnosis and/or phototherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phosphatidylserine-blocking nanoparticles as improved anti-thrombotic with reduced bleeding risk
Instantaneous Tumor Spray for Real-Time Surgical Guidance
Instantaneous Tumor Spray for Real-Time Surgical Guidance
Topical Drug Treatment of Cutaneous Leishmaniasis
海外基金